Randomised controlled trialindependent cross-checkabstract checked★ key study I-DIAB-109 in-depth review

Checking blood ketones on sick days in young people with type 1 diabetes

Sick day management using blood 3-hydroxybutyrate (3-OHB) compared with urine ketone monitoring reduces hospital visits in young people with T1DM: a randomized clinical trial.

Overview

Laffel LM et al.. Diabet Med 2006 · PMID 16492211 · DOI 10.1111/j.1464-5491.2005.01771.x

Young people who checked blood ketones when sick needed hospital or emergency care about half as often as those using urine strips.

Does the study support the specific claim? No · Methodological quality: moderate

Original publication

Plain-language summary

Study explained simply
What did the researchers want to find out?

Compare blood vs urine ketone testing.

How was the study done?

Randomised trial.

How many people, animals or samples were studied?

123 young people.

What was actually found?

38 vs 75 hospital/emergency visits per 100 patient-years.

How large was the observed effect?

Rate ratio about 0.51.

What do the results mean in everyday life?

Measuring ketones helps avoid emergencies.

What are the study's limitations?

Small; borderline P.

What does it say about Elawady's specific claim?

Contradicts 'no need to measure acetone'.

Do the results apply to Germany and Europe?

Applicable.

What can explicitly not be concluded from this study?

Cannot give exact size of benefit.

Scientific in-depth review

1. Full reference

Authors
Laffel LM et al.
Journal
Diabet Med
Year
2006
Identifier
PMID 16492211 DOI 10.1111/j.1464-5491.2005.01771.x
Verification
verified – PubMed efetch 2026-10-26; Crossref 2026-10-26
Retracted
no
Corrections
none
Extent checked
abstract only
Conflicts of interest and funding

Non-US government support (record).

2. Research question

Does blood ketone monitoring on sick days reduce hospitalisation/emergency assessment versus urine ketones?

3. Study design and population

Study design
Randomised controlled trial – Two-centre randomised clinical trial (6 months)
Population

Children, adolescents and young adults 3-22 with T1D

Country

USA (two centres)

Period

6 months

Sample size

123 (62 vs 61)

Inclusion and exclusion criteria

T1D aged 3-22

4. Methods and endpoints

Exposure / intervention

Blood 3-OHB meter

Comparator

Urine ketone strips

Endpoints

Hospitalisation/emergency assessment; ketone checking

Statistical methods

Rate comparison

5. Actual results

Results

Ketones checked on 90.8% vs 61.3% of sick days; hospitalisation/emergency assessment 38 vs 75 per 100 patient-years (P=0.05).

Absolute risks

37 fewer hospital/emergency visits per 100 patient-years

Authors' conclusion

Blood ketone monitoring can potentially reduce hospitalisation/emergency assessment.

6. Strengths

  • Randomised

7. Weaknesses

  • Small
  • Borderline significance
  • Not blinded

8. Risk of bias

Orienting tool
RoB 2
Type of assessment
simplified assessment (abstract only)
Full formal assessment
no
Overall risk of bias
some concerns
Rationale

Open-label.

9. Assessment of the statistical interpretation

Rate ratio about 0.51; CI not recomputable (stats/C-DIAB-02_laffel.py).

10. Relevance to the specific claim

Measuring ketones during illness helps prevent emergencies; the opposite of 'no need to measure'.

11. Independent contrary findings

12. Transferability to Germany and Europe

Directly applicable; same biology and clinical standards in Europe.

13. Overall methodological judgement

Moderate-quality support for ketone monitoring.

Multidimensional assessment
Multidimensional assessment
Authenticity of the sourceverified
Methodological qualitymoderate
Risk of biassome concerns
Precision of resultslow
Directnessdirect
Reproducibilitynot replicated
Consistency with the overall evidenceconsistent
Regional transferabilityhigh
Adequacy of the interpretation (by the archive)not applicable

14. Open questions

15. Linked fact checks